Zentalis Pharmaceuticals, Inc. Members' Equity
Zentalis Pharmaceuticals, Inc. (ZNTL) had Members' Equity of $433.80 million as of 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Balance Sheet › Equity › Limited Liability Company (LLC) Members' Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MembersEquity · last filed 2023-03-01
- 2022-12-31: Members' Equity $433.80M.
- 2021-12-31: Members' Equity $363.95M.
- 2020-12-31: Members' Equity $308.58M.
- 2020-09-30: Members' Equity $341.06M.
| Period end | Members' Equity |
|---|---|
| 2022-12-31 | $433.80M 10-K · filed 2023-03-01 |
| 2021-12-31 | $363.95M 10-K · filed 2023-03-01 |
| 2020-12-31 | $308.58M 10-K · filed 2022-02-24 |
| 2020-09-30 | $341.06M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $213.22M 10-Q · filed 2020-08-13 |
| 2020-03-31 | -$95.90M 10-Q · filed 2020-05-15 |
| 2019-12-31 | -$80.11M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |